Business Description
Alaunos Therapeutics is a Houston-based biopharmaceutical company founded in 2003, working on treatments for cancer, obesity, and metabolic conditions. Its obesity program centers on an oral drug candidate designed to improve on existing injectable options by protecting lean muscle mass alongside fat loss. The company also runs a TCR discovery platform aimed at identifying cancer-driving mutations, and conducts research into how its compounds affect fat storage and gene activity.
